Fed’s Powell opens door to potential rate cuts at Jackson Hole
On Thursday, Stifel analysts maintained a Buy rating and a $66.00 price target for GXO Logistics Inc. (NYSE: GXO) stock, representing a potential 67% upside from the current price of $39.46. The logistics company, with a market capitalization of $4.46 billion, reported its first quarter earnings for 2025, with an adjusted EPS of $0.29, surpassing both the consensus estimate of $0.25 and Stifel’s own forecast of $0.26. According to InvestingPro analysis, the stock is currently trading below its Fair Value. In a climate where many companies are revising forecasts, GXO Logistics stood out by reaffirming its guidance for the full year.
The analysts pointed out that concerns which had previously impacted the stock, such as contract realignments in the fourth quarter of 2024 and the pending approval of the acquisition of Wincanton, are expected to be resolved shortly. The increased exposure to the European market, once considered a potential risk, is now seen as a beneficial factor for the company’s growth strategy.
The recent contract award from the National Health Service (NHS) in the United Kingdom (TADAWUL:4280) is anticipated to enhance GXO Logistics’ expansion into the healthcare sector. Stifel continues to view GXO as an attractive Growth at a Reasonable Price (GARP) investment opportunity over the medium term, citing the company’s solid performance and strategic initiatives.
In other recent news, GXO Logistics reported its first-quarter 2025 earnings, exceeding analyst expectations with an earnings per share (EPS) of $0.29, surpassing the forecast of $0.25. The company also outperformed revenue projections, reporting $3 billion against the anticipated $2.93 billion, marking a 21% year-over-year increase. GXO Logistics is currently focusing on the successful integration of its Wincanton acquisition and advancements in AI and automation technologies to drive future growth. The company has projected organic revenue growth between 3% and 6% for the full year 2025, with adjusted EBITDA expected to range from $840 million to $860 million.
GXO Logistics has also been recognized for its efforts in the healthcare sector, finalizing a significant contract with the UK National Health Services supply chain, which carries a lifetime value of about $2.5 billion. The ongoing integration of Wincanton is expected to yield $58 million in cost synergies. Despite macroeconomic pressures and potential tariffs, GXO Logistics remains confident in its business model, which is designed to provide flexibility and resilience. The company has also been named to the Forbes Diamond List in Poland and listed as a top 500 employer in the UK by the Financial Times.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.